6-((3S,4R)-3,4-dihydroxypyrrolidin-1-yl)-2-((S)-3-hydroxy-3-methylpyrrolidin-1-yl)-4-(trifluoromethyl)nicotinonitrile

ID: ALA4762437

PubChem CID: 154585747

Max Phase: Preclinical

Molecular Formula: C16H19F3N4O3

Molecular Weight: 372.35

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@]1(O)CCN(c2nc(N3C[C@@H](O)[C@@H](O)C3)cc(C(F)(F)F)c2C#N)C1

Standard InChI:  InChI=1S/C16H19F3N4O3/c1-15(26)2-3-22(8-15)14-9(5-20)10(16(17,18)19)4-13(21-14)23-6-11(24)12(25)7-23/h4,11-12,24-26H,2-3,6-8H2,1H3/t11-,12+,15-/m0/s1

Standard InChI Key:  FAXXYODRCHXHTQ-ZOWXZIJZSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    4.5914  -12.4701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3081  -12.8826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3069  -12.0558    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0233  -15.3907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0222  -16.2181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7369  -16.6309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4533  -16.2176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4505  -15.3871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7351  -14.9781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7268  -14.1522    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3927  -13.6653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1354  -12.8814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0580  -13.6692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1689  -16.6266    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2565  -17.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0637  -17.6171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4751  -16.9020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9219  -16.2899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4004  -18.3702    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2954  -16.8143    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3094  -14.9790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5948  -14.5667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3073  -16.6300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5933  -16.2170    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.3067  -17.4550    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.5873  -17.0365    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  1
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  1  0
 11 12  1  0
 12  2  1  0
  2 13  1  0
 13 10  1  0
  9 10  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
  7 14  1  0
 16 19  1  1
 17 20  1  1
 21 22  3  0
  4 21  1  0
  5 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4762437

    ---

Associated Targets(Human)

KHK Tchem Ketohexokinase (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.35Molecular Weight (Monoisotopic): 372.1409AlogP: 0.47#Rotatable Bonds: 2
Polar Surface Area: 103.85Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.45CX Basic pKa: 3.71CX LogP: 1.00CX LogD: 1.00
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.69Np Likeness Score: -0.60

References

1. Futatsugi K,Smith AC,Tu M,Raymer B,Ahn K,Coffey SB,Dowling MS,Fernando DP,Gutierrez JA,Huard K,Jasti J,Kalgutkar AS,Knafels JD,Pandit J,Parris KD,Perez S,Pfefferkorn JA,Price DA,Ryder T,Shavnya A,Stock IA,Tsai AS,Tesz GJ,Thuma BA,Weng Y,Wisniewska HM,Xing G,Zhou J,Magee TV.  (2020)  Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose.,  63  (22): [PMID:32910646] [10.1021/acs.jmedchem.0c00944]

Source